EC approves amendment of Valneva’s Covid-19 vaccines purchase deal
The EC member states will now buy 1.25 million doses of VLA2001 this year after amending the previous purchase deal.

The EC member states will now buy 1.25 million doses of VLA2001 this year after amending the previous purchase deal.
The new facility will house fermenters that will be capable of handling capacities of 185,000l.
Sandoz intends to invest $183m (€150m) to boost its European antibiotics manufacturing network.
GlaxoSmithKline (GSK) and CureVac have entered a €150m ($180m) collaboration to jointly develop mRNA vaccines for Covid-19.
Swiss pharmaceutical company Novartis unit Sandoz has partnered with the Austrian Government to boost integrated antibiotics production in Europe.
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial…
Austria-based OncoOne closed its Series A funding round with €13m raised. This financing will be used to officially launch the…
ByGlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual sales of £9.8bn ($12.7bn) and…
Thank you for subscribing to Pharmaceutical Technology